Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Agha A et al. - Losartan, an ARB, demonstrated significant anti-albuminuric ability in normotensive patients with T2DM with early nephropathy independent of hypertension. Losartan was well tolerated in the study with desirable anti albuminuric effects. The authors recommend that further large-scale long-term prospective placebo controlled clinical trials should be done in normotensive diabetic patients using ARBs. More evidence is needed to advocate early start of these drugs in T2DM patients with normal blood pressures in order to prevent morbidity and mortality associated with diabetic nephropathy.

Today in Endocrinology...keeping you current

Stone composition and metabolic status
Urological Research - Urolithiasis, 11/25/09

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology, 11/20/09

Today in Pharmacology/kinetics...keeping you current

Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrology Dialysis Transplantation, 11/25/09

Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone
Hypertension, 11/24/09

Bilateral renal inflammatory pseudotumour effectively treated with corticosteroid
Clinical and Experimental Nephrology, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address